The pancreas is a glandular organ in the upper abdomen posterior to stomach. - PowerPoint Presentation

Slide1

The pancreas is a glandular organ in the upper abdomen posterior to stomach.

It serves as two glands in one: a digestive exocrine gland and a hormone-producing endocrine gland.

Functioning as an exocrine gland, the pancreas excretes enzymes to break down the proteins, lipids, carbohydrates in food. Functioning as an endocrine gland, the pancreas secretes the hormones insulin and glucagon to control blood sugar levels throughout the day

PANCREAS

Slide2

Slide3

Unstable if taken orally,

metabolised

by the kidneyInsulin maintains normal blood glucose levels by

facilitating cellular glucose uptake

regulating carbohydrate, lipid and protein metabolism

promoting cell division and growth through its

mitogenic

effects.

Slide4

INSULIN SECRETION IN BETA CELLS

Slide5

REGULATION OF INSULIN SECRETION

GLP-1 = glucagon-like peptide 1

ATP = adenosine triphosphateADP = adenosine diphosphatecAMP= cyclic adenosine monophosphatePACAP = pituitary

adenylate

cyclase

-activating polypeptide

DAG =

diacylglycerol

GIP = gastric inhibitory peptide /

glucose-dependent

insulinotropic

polypeptide

PKC = protein

kinase CGlucose- 6- P = glucose 6 phosphateGLUT 2 = glucose transport protein 2GLUT 4 = glucose transport protein 4VIP= vasoactive intestinal peptide

Parasympathetic(AC)/sympathetic (NE)

Slide6

Slide7

Akt

/PKB = protein

kinase BPIPD1 & 2 = phosphatidylinositol dependent protein kinases 1 & 2

IRS = insulin receptor substrate

ADP = adenosine

diphosphate

MAP

kinase

=

mitogen

activated protein

kinase

cAMP

= cyclic adenosine

monophosphateDAG = diacylglycerolPI3K = phosphatidylinositol 3-kinase

PKC = protein

kinase

C

RAS = rat sarcoma protein

GLUT 2 = glucose transport protein 2

SHC =adaptor protein with

src-homologyGLUT 4 = glucose transport protein 4

RAS dependent

RAS independent

RTK

Increased protein synthesis- increased tissue growth

Slide8

Functions of Insulin

Slide9

Slide10

Diabetes/ Diabetes mellitus

, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body's cells do not respond properly to insulin, or both. 

Slide11

Increased breathing to compensate for increased plasma PaCO2 and decreased pH

Slide12

Urinary Glucose

Fasting Blood Glucose and Insulin Levels

.

FBG levels in the early morning is normally 80-90 mg/100 ml.

FBG above 110 mg/100 ml often indicates diabetes

In type I diabetes, plasma insulin levels are very low or undetectable during fasting and even after a meal

.

Acetone Breath

Increased Acetoacetic acid in the blood is converted to acetone. This is volatile and vaporized into the expired air.

Consequently, one can frequently make a diagnosis of type I diabetes mellitus simply by smelling acetone on the breath of a patient.

DIAGNOSIS

Slide13

Slide14

Glucagon serves as the counter-balancing hormone to insulin, having largely the opposite effects.

Insulin is secreted and active during feeding and elevated blood glucose, ensuring storage of glucose in liver and other tissues (anabolic activity) glucagon ensures the release of glucose from liver when blood glucose is low during fasting and exercise (catabolic activity).

Glucagon is a 29 amino acid protein with a very short half-life in the blood. 

Slide15

Glucose is incorporated into the α-cell by the transporter SLC2A1.

At low-glucose concentrations, the moderate activity of KATP channels situates the α-cell membrane potential in a range that allows the opening of voltage-dependent T- and N-type Ca

2+ channels and voltage-dependent Na+ channels. Their activation triggers action potentials, Ca2+ influx and exocytosis of glucagon granules.

glucose-dependent regulation of glucagon secretion in the α-cell.

Slide16

GPCRs,

β-adrenergic receptor

Glucagon receptors are mainly expressed in liver and in kidney with lesser amounts found in heart, adipose tissue, spleen, thymus, adrenal glands, pancreas, cerebral cortex, and gastrointestinal tract. The binding of glucagon to the receptors results in activation of adenylyl cyclase and generation of the second messenger cyclic AMP, which in turn activates protein kinase, leading to phosphorylation

that results in the activation or deactivation of a number of enzymes.

Slide17

The binding of glucagon and epinephrine ultimately lead to protein

phosphorylation

by the activation of protein kinases while the binding of insulin ultimately leads to activation of protein phosphatases which remove the phosphate groups from enzymes.

The hormones glucagon, epinephrine, and insulin all bind reversible to receptors on the cell surface.

Slide18

Slide19

Slide20

Its analogous Gastric inhibitory polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1), secreted from the intestine on ingestion of glucose or nutrients to stimulate insulin secretion from pancreatic β cells.

Both GLP1 and

Amylin have anti-obesity potentialAmylin (islet amyloid polypeptide, or IAPP) is a 37–amino acid peptide hormone  that is cosecreted with insulin from the pancreatic β-cell and is thus deficient in diabetic people.

It inhibits glucagon secretion, delays gastric emptying, and acts as a satiety agent.

Amylin

A stable analog,

pramlintide

, new approach for diabetes treatment

Gastric grinding, liquefication

Slide21

 PP secreted by F cells & belongs to the family of PYY & NPY peptides.

PP has effects on GI motility, metabolism and food intake and is stimulated by

vagus nerve.  Acts as satiety factor, PP secretion is absent in obese children with Prader-Willi syndrome.

Its primary action on the exocrine pancreas is to inhibit secretion in vivo by acting on receptors in the brain leading to inhibition of vagal output to the pancreas.

Pancreatic Polypeptide (PP) is a 36 amino acid peptide

Slide22

Diseases of pancreas

Pancreatitis -inflammation of the pancreas that occurs when pancreatic enzyme secretions build up and begin to digest the organ itself. It can occur as acute painful attacks lasting a matter of days, or it may be a chronic condition that progresses over a period of years.

Precursors to Pancreatic Cancer-known risk factors that increase the risk of developing the disease are cigarette smoking, a family history of pancreatic cancer or hereditary cancer syndromes, and chronic pancreatitis are some of these factors. In addition, certain pancreatic lesions such as Intraductal Papillary Mucinous Neoplasms (IPMNs) and Pancreatic Intraepithelial Neoplasia (PanIN) are considered precursors to pancreatic cancer.Pancreatic Cancer-The most common form of pancreatic cancer is pancreatic adenocarcinoma, an exocrine tumor arising from the cells lining the pancreatic duct. A far less common form, endocrine tumors, account for less than 5% of all pancreatic tumors and are sometimes referred to as

neuroendocrine or islet cell tumors.

Slide23

The thymus gland (endocrine as well as lymphatic) is located behind the sternum and between lungs, is only active until puberty.

 The thymus (a gland associated with the immune system), is enclosed in a capsule and divided internally by cross-walls into many lobules (full of T-lymphocytes).In relation to body size the thymus is largest at birth. It doubles in size by puberty, after which it gradually shrinks, its functional tissue being replaced by fatty tissue

In infancy the thymus controls the development of lymphoid tissue and the immune response to microbes and foreign proteins. T-lymphocytes migrate from the bone marrow to the thymus, where they mature and differentiate until activated by antigen.

Thymosin

Activates the immune system by activating the T-Cells (T-Killer Cells; T-Helper Cells; T-Memory Cells). 

helps the body protect itself against autoimmunity,

There are two main kinds of thymus cancer:

thymoma

and

thymic

carcinoma, and both are rare.